The 'dark matter' of biology could help medical professionals determine which cancer treatments will work best for a specific patient, new research claims.
Two new studies published simultaneously in the journal Nature reveal how epigenetics plays a central role in the development and progression of bowel cancer.
Professor Trevor Graham, Director of the Centre for Evolution and Cancer at the ICR, explains: "We’ve unveiled an extra level of control for how cancers behave – something we liken to cancer’s ‘dark matter’."
